PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
VYNE vs. VGSTX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between VYNE and VGSTX is 0.26, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

VYNE vs. VGSTX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in VYNE Therapeutics Inc. (VYNE) and Vanguard STAR Fund (VGSTX). The values are adjusted to include any dividend payments, if applicable.

-100.00%-80.00%-60.00%-40.00%-20.00%0.00%20.00%SeptemberOctoberNovemberDecember2025February
-99.88%
17.72%
VYNE
VGSTX

Key characteristics

Sharpe Ratio

VYNE:

0.29

VGSTX:

0.97

Sortino Ratio

VYNE:

1.01

VGSTX:

1.29

Omega Ratio

VYNE:

1.12

VGSTX:

1.19

Calmar Ratio

VYNE:

0.23

VGSTX:

0.51

Martin Ratio

VYNE:

0.81

VGSTX:

3.74

Ulcer Index

VYNE:

28.23%

VGSTX:

2.53%

Daily Std Dev

VYNE:

78.47%

VGSTX:

9.73%

Max Drawdown

VYNE:

-99.94%

VGSTX:

-43.45%

Current Drawdown

VYNE:

-99.91%

VGSTX:

-11.02%

Returns By Period

In the year-to-date period, VYNE achieves a -26.27% return, which is significantly lower than VGSTX's 4.37% return.


VYNE

YTD

-26.27%

1M

-8.52%

6M

32.80%

1Y

8.81%

5Y*

-63.68%

10Y*

N/A

VGSTX

YTD

4.37%

1M

2.83%

6M

0.83%

1Y

8.00%

5Y*

2.17%

10Y*

3.30%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

VYNE vs. VGSTX — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VYNE
The Risk-Adjusted Performance Rank of VYNE is 5656
Overall Rank
The Sharpe Ratio Rank of VYNE is 5656
Sharpe Ratio Rank
The Sortino Ratio Rank of VYNE is 5858
Sortino Ratio Rank
The Omega Ratio Rank of VYNE is 5555
Omega Ratio Rank
The Calmar Ratio Rank of VYNE is 5555
Calmar Ratio Rank
The Martin Ratio Rank of VYNE is 5555
Martin Ratio Rank

VGSTX
The Risk-Adjusted Performance Rank of VGSTX is 4242
Overall Rank
The Sharpe Ratio Rank of VGSTX is 4242
Sharpe Ratio Rank
The Sortino Ratio Rank of VGSTX is 3939
Sortino Ratio Rank
The Omega Ratio Rank of VGSTX is 4444
Omega Ratio Rank
The Calmar Ratio Rank of VGSTX is 3535
Calmar Ratio Rank
The Martin Ratio Rank of VGSTX is 4949
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

VYNE vs. VGSTX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for VYNE Therapeutics Inc. (VYNE) and Vanguard STAR Fund (VGSTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for VYNE, currently valued at 0.29, compared to the broader market-2.000.002.004.000.290.97
The chart of Sortino ratio for VYNE, currently valued at 1.01, compared to the broader market-6.00-4.00-2.000.002.004.006.001.011.29
The chart of Omega ratio for VYNE, currently valued at 1.12, compared to the broader market0.501.001.502.001.121.19
The chart of Calmar ratio for VYNE, currently valued at 0.23, compared to the broader market0.002.004.006.000.230.51
The chart of Martin ratio for VYNE, currently valued at 0.81, compared to the broader market-10.000.0010.0020.0030.000.813.74
VYNE
VGSTX

The current VYNE Sharpe Ratio is 0.29, which is lower than the VGSTX Sharpe Ratio of 0.97. The chart below compares the historical Sharpe Ratios of VYNE and VGSTX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.001.502.002.50SeptemberOctoberNovemberDecember2025February
0.29
0.97
VYNE
VGSTX

Dividends

VYNE vs. VGSTX - Dividend Comparison

VYNE has not paid dividends to shareholders, while VGSTX's dividend yield for the trailing twelve months is around 2.33%.


TTM20242023202220212020201920182017201620152014
VYNE
VYNE Therapeutics Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
VGSTX
Vanguard STAR Fund
2.33%2.43%2.21%2.08%1.36%1.42%2.11%2.52%1.85%2.08%2.09%2.18%

Drawdowns

VYNE vs. VGSTX - Drawdown Comparison

The maximum VYNE drawdown since its inception was -99.94%, which is greater than VGSTX's maximum drawdown of -43.45%. Use the drawdown chart below to compare losses from any high point for VYNE and VGSTX. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-99.91%
-11.02%
VYNE
VGSTX

Volatility

VYNE vs. VGSTX - Volatility Comparison

VYNE Therapeutics Inc. (VYNE) has a higher volatility of 14.39% compared to Vanguard STAR Fund (VGSTX) at 2.15%. This indicates that VYNE's price experiences larger fluctuations and is considered to be riskier than VGSTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%SeptemberOctoberNovemberDecember2025February
14.39%
2.15%
VYNE
VGSTX
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab